Approach enlists immune system to fight leukemia
CHICAGO (Reuters) - Leukemia patients may be able to avoid developing resistance to the drug Gleevec through a mathematical formula that predicts when they should receive an immune-boosting vaccine, researchers said on Thursday.
<p><img src="http://feeds.feedburner.com/~a/reuters/scienceNews?i=grJeyG" border="0"></img> (http://feeds.feedburner.com/~a/reuters/scienceNews?a=grJeyG)</p><div class="feedflare">
<img src="http://feeds.feedburner.com/~f/reuters/scienceNews?i=WSvNkI" border="0"></img> (http://feeds.feedburner.com/~f/reuters/scienceNews?a=WSvNkI) <img src="http://feeds.feedburner.com/~f/reuters/scienceNews?i=AsmQLi" border="0"></img> (http://feeds.feedburner.com/~f/reuters/scienceNews?a=AsmQLi) <img src="http://feeds.feedburner.com/~f/reuters/scienceNews?i=vGai2i" border="0"></img> (http://feeds.feedburner.com/~f/reuters/scienceNews?a=vGai2i)
</div><img src="http://feeds.feedburner.com/~r/reuters/scienceNews/~4/315827649" height="1" width="1"/>
http://feeds.feedburner.com/~r/reuters/scienceNews/~3/315827649/idUSN1932621420080620